other material
confidence high
sentiment neutral
materiality 0.50
Indaptus Therapeutics extends $24M private placement outside date to October 16, 2026
Indaptus Therapeutics, Inc.
- Indaptus Therapeutics and the purchasers signed Notices and Consents on September 29, 2026 extending the Stock Purchase Agreement outside date from September 29 to October 16, 2026.
- The September 8, 2026 Stock Purchase Agreement covers a private placement of common stock for aggregate gross proceeds of approximately $24.0 million before expenses.
- Closing may be deferred and coordinated across purchasers until Section 7 conditions are satisfied or waived, but no later than the Extended Outside Date.
- The funding deadline and related termination rights were extended to October 16, 2026, and the 60-day period under Section 3.1 now begins after the Extended Outside Date.
- The company may retain previously delivered Subscription Amounts pending closing without breaching the agreement; CEO Junyi Dai signed the filing on September 30, 2026.